Although anti-mPD-1 therapy did not significantly change the overall Treg proportion, CD8α+ and PD-1+ T cell populations in the lymph nodes were substantially expanded, suggesting that PD-1 inhibition may transiently relieve Treg mediated suppression, thereby enhancing the anti-tumor T cell response. The gene discussed is CD8A; the disease is neoplasm.